Acute Porphyria Drug Database

Monograph

R01BA01 - Phenylpropanolamine
Not porphyrinogenic
NP

Rationale
Not metabolised.
Chemical description
Adrenergic for peroral administration in allergic and vasomotor rhinitis. Excreted in urine in unchanged form. C.Andersson, patient reports: tolerated (n=1)
IPNet drug reports
Uneventful use reported in 16 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes R01B / R01BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Phenylpropanolamine · Phenylpropanolamine 25mg/5ml oral solution · Phenylpropanolamine 25mg/5ml oral suspension · Phenylpropanolamine 50mg capsules
Norway
Rinexin
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙